Radiofrequency catheter ablation and nerve growth factor concentration in humans

Heart Rhythm. 2006 Oct;3(10):1150-5. doi: 10.1016/j.hrthm.2006.06.033. Epub 2006 Jul 8.

Abstract

Background: In animal models, expression of nerve growth factor (NGF) is increased after necrotic myocardial injury. Whether radiofrequency (RF) catheter ablation increases NGF expression in humans is unclear.

Objectives: The purpose of this study was to determine NGF concentrations in the aorta, coronary sinus, and peripheral veins before and after RF ablation in patients.

Methods: We sampled blood from aorta and either great cardiac vein (group 1, N = 18) or proximal (group 2, N = 20) coronary sinus before and after RF ablation. In group 3 (N = 21), peripheral venous blood was sampled before and after RF ablation and then up to postoperative day 7. In group 4 (N = 10), we sampled peripheral venous blood during diagnostic electrophysiologic study. The NGF concentration was determined by enzyme-linked immunosorbent assay. Transcardiac NGF concentration was the difference in NGF concentrations between coronary sinus and aorta.

Results: There was no change in transcardiac NGF concentrations in groups 1 and 2. In group 3, the NGF level did not change significantly from before the procedure (17.10 +/- 15.80 ng/mL) to immediately after the procedure (14.46 +/- 10.36 ng/mL). However, NGF levels increased significantly to 31.24 +/- 19.82 ng/mL (N = 21, P <.0001) on postoperative day 1, 26.23 +/- 16.89 ng/mL (N = 20, P <.001) on postoperative day 2, and 22.01 +/- 11.35 ng/mL (N = 16, P = .003) on postoperative day 3. NGF concentrations did not change significantly in group 4.

Conclusion: RF ablation did not result in a detectable increase of transcardiac NGF concentration immediately after the procedure. However, the systemic NGF concentration increased significantly on postoperative days 1 to 3, suggesting that RF ablation resulted in increased NGF expression.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation / blood*
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / surgery*
  • Biomarkers / blood
  • Catheter Ablation*
  • Coronary Vessels
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Femoral Artery
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Nerve Growth Factor / blood*
  • Prognosis
  • Recurrence

Substances

  • Biomarkers
  • Nerve Growth Factor